Relationship between delay in radiotherapy and biochemical control in prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 3, 2006, Pages 663-668

  Kwan, Winkle ^a   Pickles, Tom ^a   Duncan, Graeme ^a   Liu, Mitchell ^a   Paltiel, Chuck ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Delay; Prostate carcinoma; Prostate specific antigen outcome; Radiotherapy

Indexed keywords

ANTIGENS; BIOCHEMISTRY; DIAGNOSIS; DISEASE CONTROL; DISEASES; TUMORS;

DELAY; PROSTATE CARCINOMA; PROSTATE-SPECIFIC ANTIGEN OUTCOME;

RADIOTHERAPY;

HORMONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; RADIATION DOSE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

AGED; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TIME FACTORS;

EID: 33748939564     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.05.043     Document Type: Article

References (20)

1. Fortin A., Bairati I., Albert M., et al. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys 52 (2002) 929-936
2. Bastit L., Blot E., Debourdeau P., et al. Influence of the delay of adjuvant postoperative radiotherapy on relapse and survival in oropharyngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 49 (2001) 139-146
3. Dixit S., Vyas R.K., Toparani R.B., et al. Surgery versus surgery and postoperative radiotherapy in squamous cell carcinioma of the buccal mucosa: a comparative study. Ann Surg Oncol 5 (1998) 502-510
4. Richards M.A., Westcombe A.M., Love S.B., et al. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 353 (1999) 1119-1126
5. Do V., Gebski V., and Barton M.B. The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol 57 (2000) 131-136
6. Nam R.K., Jewett M.A., Krahn M.D., et al. Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy. Can J Urol 10 (2003) 1891-1898
7. Khan M.A., Mangold L.A., Epstein J.I., et al. Impact of surgical delay on long-term cancer control for clinically localized prostate cancer. J Urol 172 (2004) 1835-1839
8. Nguyen P.L., Whittington R., Koo S., et al. The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma. Cancer 103 (2005) 2053-2059
9. Kwan W., Pickles T., Duncan G., et al. PSA failure and the risk of death in prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 1040-1046
10. Kim-Sing C., Pickles T., and Prostate Cohort Outcomes Initiative. Intervention after PSA failure: Examination of intervention time and subsequent outcomes from a prospective patient database. Int J Radiat Oncol Biol Phys 60 (2004) 463-469
11. Lukka H., Hayter C., Julian J.A., et al. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol 23 (2005) 6132-6138
12. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus Statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
13. Lukka H., Warde P., Pickles T., et al. Controversies in prostate cancer radiotherapy: consensus development. Can J Urol 8 (2001) 1314-1322
14. Pollack A., Zagars G., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
15. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate, a randomized controlled trial. JAMA 294 (2005) 1233-1239
16. Andrews S.F., Horwitz E.M., Feigenberg S.J., et al. Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma?. Cancer 104 (2005) 299-304
17. Asbell S.O., Krall J.M., Pilepich M.V., et al. Elective pelvic irradiation in stage A2, B carcinoma of the prostate: Analysis of RTOG 77-06. Int J Radiat Oncol Biol Phys 15 (1988) 1307-1316
18. Roach III M., DeSilvio M., Lawton C., et al., Radiation Therapy Oncology Group 9413. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression. Int J Radiat Oncol Biol Phys 21 (2003) 1904-1911
19. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradatiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomized trial. Lancet 360 (2002) 103-106
20. Pilepich M.V., Winter K., Lawton C.A., et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-Long-term results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 61 (2005) 1285-1290